GenoSensor Corporation is a genomic technology company founded in 2003 and headquartered in the United States. The company's slogan "We focus on genomic technologies and provide complete solutions for gene profiling and screening for all life science" reflects its dedication to providing comprehensive genomic solutions.
GenoSensor Corporation specializes in developing and marketing products and services for genomic research, drug discovery, predisposition gene screening, therapeutic assessment, and other bioscience applications. The company's focus is on serving customers who conduct genomic research and require genomic solutions across all life sciences. Additionally, GenoSensor develops assays tailored for specific applications.
Through the integration of high-throughput laboratory and microarray fabrication facilities, GenoSensor has emerged as a leading company in bioassay services and development on a national scale. Its genetic products and services are utilized by laboratories worldwide for sample processing, nucleic acid preparation, genetic profiling, and gene screening. The company offers full services, encompassing sample-in and data-out genomic experimentations for gene expression profiling, genotyping, sequencing, and other genomic research applications. Notably, its production pipelines are robust, highly reproducible, reliable, cost-effective, and feature rapid turnaround times. GenoSensor's dedication to meeting the individualized needs of its customers is a key goal.
There is no investment information
No recent news or press coverage available for GenoSensor Corporation.